Clipping of news on Brazilian Culture, Law and Citizenship
17/07/2012
This article was translated by an automatic translation system, and was therefore not reviewed by people.
Clinical trials have shown that drug may reduce the risk of HIV by 73%
The Federal Bureau of Food and Drug Administration (FDA) of the United States announced on Monday (16) the approval of Truvada, Gilead Sciences Laboratory, as the first pill to help prevent HIV in some risk groups. The FDA said:
- Truvada is to use pre-exposure prophylaxis in combination with safe sex practices to prevent HIV infections acquired through sexual transmission in high-risk adults. Truvada is the first drug approved for this indication.
Truvada is found in the American market since 2004 as a treatment for people infected with HIV, indicated in combination with other antiretroviral drugs.
In May, an advisory panel urged the FDA to approve Truvada as prevention for people not infected after clinical trials showed that this drug can reduce the risk of HIV in gay men 44 to 73%.
Source: R7 News
Our news are taken in full of our partner sites. For this reason, we can not change the content of these up in case of typing errors.
This article was translated by an automatic translation system, and was therefore not reviewed by people.